Moderate-Intensity Rosuvastatin Plus Ezetimibe Versus High-Intensity Rosuvastatin for Target Low-Density Lipoprotein Cholesterol Goal
To assess the efficacy and safety of moderate-intensity rosuvastatin/ezetimibe compared to high-intensity rosuvastatin in high
by IH Yang 2024The combination of low intensity rosuvastatin and ezetimibe showed greater decrement of serum LDL-C level when compared with moderate intensity rosuvastatin.
Moderate-Intensity (MI). Low-Intensity (LI). Daily dose lowers LDL-C on Rosuvastatin (Crestor) mg. Atorvastatin mg. Rosuvastatin 5-10 mg.
by JS Moon Cited by 1The efficacy and safety of moderate-intensity rosuvastatin with Ezetimibe versus high-intensity rosuvastatin in high atherosclerotic cardiovascular disease
These findings suggest that the combination therapy of low-intensity rosuvastatin and ezetimibe is an useful alternative to moderate-intensity rosuvastatin monotherapy for cholesterol management
by IH Yang 2024The combination of low intensity rosuvastatin and ezetimibe showed greater decrement of serum LDL-C level when compared with moderate intensity rosuvastatin.
Background: To investigate the efficacy and safety of moderate-intensity rosuvastatin/ezetimibe combination compared to highintensity rosuvastatin in high
by IH Yang 2024The combination of low intensity rosuvastatin and ezetimibe showed greater decrement of serum LDL-C level when compared with moderate intensity rosuvastatin.
Grin!